期刊文献+

非酒精性脂肪肝患者肝酶与C反应蛋白、胰岛素抵抗关系的研究

The relationships between the changes of liver enzymes and changes of insulin resistance,C-reactive protein in patients with non-alcoholic fatty liver
暂未订购
导出
摘要 目的探讨非酒精性脂肪肝患者肝酶的变化与其胰岛素抵抗、C反应蛋白的变化的关系。方法 2007年9月至2009年9月收治的非酒精性脂肪肝病人,肝酶异常的56例,肝酶正常的62例,两组性别、年龄、体重、腰围、臀围比较无差异。禁食10h后,于第2天晨起抽取静脉血,测肝功能、空腹血糖、空腹胰岛素、C反应蛋白。结果肝酶异常组的FBG、FINS、CRP及胰岛素抵抗指数与肝酶正常组比较均有显著差异,非酒精性脂肪肝肝酶的异常与FBG、FINS、CRP及胰岛素抵抗指数的变化有关。结论肝酶异常与FBG、FINS、HOMA-IR的变化有关,另外非酒精性脂肪肝肝酶异常与CRP升高也有着密切关系。非酒精性脂肪肝一旦出现肝酶升高,同样提示肝脏有进展的炎症病变,尽早有效治疗可以防止肝脏纤维化、肝硬化的发生。 Objective To explore the relationships between the changes of liver enzymes and changes of insulin resistance,C-reactive protein in patients with non-alcoholic fatty liver.Methods 118 patients with non-alcoholic fatty liver during Sep,2007 to Sep,2009 were treated,56 with abnormal liver enzymes,62 with normal.There was no difference among the gender,age,weight,waist circumference,hip circumference in the two groups.After fasting 10 hours,in the early morning of next day the liver function,fasting glucose, fasting insulin and C-reactive protein were detected.Results The results showed that the levels of FBG,FINS,CRP and insulin resistance index were different.Conclusion We should give more concern for the patients with NAFL and abnormal liver enzymes.The treatment of NAFL can improve the statuses of liver and prevent the fibrosis and cirrhosis of the liver.
出处 《医学研究与教育》 CAS 2010年第6期34-35,49,共3页 Medical Research and Education
关键词 非酒精性脂肪肝 肝酶 C反应蛋白 胰岛素抵抗 non-alcoholic fatty liver liver enzymes C-reactive protein insulin resistance
  • 相关文献

参考文献5

二级参考文献27

  • 1Frohlich M, Beiner H, Imbof A, et al. Association between c-reactive protein and features of the metabolic syndrome. Diabetes Care, 2000,23:1835
  • 2Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with metablic syndrome. Diabetes Care, 2001,24:683
  • 3Mendall MA, Patel P, Ballam L, et al. C-reactive protein and its relation to cardiovascular risk factors: a population based croess section study.BMJ, 1996 , 312 :1061
  • 4Grau AJ ,Buggle F,Becher H,et al, The association of leucocyte count,fibroinogen and C-reactive protein with vascular risk factors and rschemic vascular diseases. Thromb Res,1996,82:245
  • 5Juhan Vague I, Thompson SG,Jespersen J. Involvement of the hemostatic system in the insulin resistance syrdrome: a study of 1 500 patients with angina pectoris: the ECTA Angina Pectoris Study Group. Arterioscler Thromb, 1993,13:1865
  • 6Ford ES. Body mass irdex, diabetes, and C-rractive protein among U. S.adults[see comments]. Diabetes Care, 1999,22(12) :1971
  • 7Visser M,Bouter LM,Geraldine MM, et al. Elevated C-reaetrye protein levels in overweight and obese adults. JAMA,1999, 282: 2131
  • 8Cook DG,Mendaii MA,Whincup PH, et al. C reactive protem concen tration in chlldren: relationship to adiposity and other cardiovasular risk factors. Atherosclerosis ,2000,149( 1 ): 139
  • 9Hak AE,Stehouwer CD,Bots ML,et al. Associations of C-reactive pro tein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle aged women. Arterioseler Thromb Va sc Biol, 1999,19(8): 1986
  • 10Pickup JC,Mattock MB,Chusney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and inter leulin-6 with metabolic syndrome X. Diabeetologia. 1997,40( 11 ): 1286

共引文献1416

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部